The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And the fact that they increase focus, they are effective although they do have their side effects. Sometimes severe, sometimes habit forming, sometimes even addicting as well. But the fact that they increase focus should automatically tell you something that those drugs in particular increase dopamine in the so-called mesocortical and mesolimbic pathways.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
And if you look at the major drugs that were developed and now marketed by pharmaceutical companies for the treatment of ADHD, those drugs have names like rolin. Nowadays, it's typically things like aderall, modafanil, and some of the other derivatives. They all serve to increase levels of dopamine. in particular dopamine in the networks that control task directed behavior and that coordinate the default mode network and these task related networks.
Now you may notice that I haven't talked much about acetylcholine. Acetylcholine is a neurotransmitter that at the neuron to muscle connections the so-called neuromuscular junctions is involved in generating muscular contractions of all kinds of all movements.